SanofiSNYNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank50
3Y CAGR-14.5%
5Y CAGR-14.8%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-14.5%/yr
vs +21.4%/yr prior
5Y CAGR
-14.8%/yr
Consistent
Acceleration
-35.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.34B | -12.5% |
| 2024 | $7.25B | +4.2% |
| 2023 | $6.96B | -31.5% |
| 2022 | $10.16B | +25.1% |
| 2021 | $8.13B | -42.4% |
| 2020 | $14.11B | +362.6% |
| 2019 | $3.05B | -34.8% |
| 2018 | $4.68B | -19.4% |
| 2017 | $5.80B | -11.1% |
| 2016 | $6.53B | - |